ストックスクリーナーアプリを入手
4.62
12.08%
-0.635
前日終値:
$5.255
開ける：
$5.41
24時間の取引高:
160.18K
Relative Volume:
2.83
時価総額：
$30.58M
収益：
$5.75M
当期純損益:
$-38.96M
株価収益率:
-0.3705
EPS:
-12.47
ネットキャッシュフロー:
$-32.63M
1週間 パフォーマンス:
+14.36%
1か月 パフォーマンス:
+13.79%
6か月 パフォーマンス:
-33.81%
1年 パフォーマンス:
-28.37%
1日の値動き範囲:
$4.36
$5.90
1週間の範囲:
$3.8217
$5.90
52週間の値動き範囲:
$2.92
$11.20
Kala Bio Inc Stock (KALA) Company Profile
KALA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
KALA
Kala Bio Inc
|
4.62 | 30.58M | 5.75M | -38.96M | -32.63M | -12.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.30 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
521.00 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.83 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
560.14 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
241.20 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Kala Bio Inc Stock (KALA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2022-03-30 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-09-14 | ダウングレード | Jefferies | Buy → Hold |
| 2020-07-23 | 開始されました | Northland Capital | Outperform |
| 2020-06-01 | 再開されました | Oppenheimer | Outperform |
| 2020-05-27 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-09 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-12-17 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2019-03-14 | 開始されました | Jefferies | Buy |
すべてを表示
Kala Bio Inc (KALA) 最新ニュース
Millennium Management LLC Purchases 17,130 Shares of HBT Financial, Inc. (NASDAQ:HBT) - Defense World
Millennium Management LLC Decreases Stake in KALA BIO, Inc. (NASDAQ:KALA) - Defense World
Nexa Resources S.A. (NYSE:NEXA) Shares Sold by Millennium Management LLC - Defense World
24,353 Shares in T. Rowe Price Floating Rate ETF (NYSEARCA:TFLR) Acquired by Bank of America Corp DE - Defense World
Cadre Holdings, Inc. (NYSE:CDRE) Shares Acquired by Millennium Management LLC - Defense World
Bank of America Corp DE Acquires 2,612 Shares of First Trust Indxx Global Natural Resources Income ETF (NASDAQ:FTRI) - Defense World
Millennium Management LLC Sells 1,791 Shares of Bluerock Homes Trust, Inc. (NYSEAMERICAN:BHM) - Defense World
Ameriprise Financial Inc. Buys 11,012 Shares of Liberty All-Star Growth Fund, Inc. (NYSE:ASG) - Defense World
Kala Bio director Mark Iwicki sells $40,638 in stock By Investing.com - Investing.com South Africa
Kala Bio director Mark Iwicki sells $40,638 in stock - Investing.com India
KALA BIO Executives Sell Shares - TradingView
Pre-market Movers: STSS, SGMT, NIVF, OGEN... - RTTNews
KALA BIO (NASDAQ:KALA) Given “Outperform” Rating at Oppenheimer - Defense World
KALA: Oppenheimer Announces Outperform Rating for Kala Bio | KALA Stock News - GuruFocus
KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | - GuruFocus
KALA Stock Gains Momentum with Oppenheimer's Positive Outlook | KALA Stock News - GuruFocus
Tidal Investments LLC Has $269,000 Stake in Air Lease Co. (NYSE:AL) - Defense World
Aegon Ltd. (NYSE:AEG) Shares Sold by Millennium Management LLC - Defense World
KALA BIO to Present at Jefferies Global Healthcare Conference - The Manila Times
KALA BIO to Reveal Latest Eye Disease Pipeline Progress at Major Jefferies Healthcare Conference - Stock Titan
Q1 Earnings Estimate for KALA BIO Issued By HC Wainwright - Defense World
HC Wainwright Lowers KALA BIO (NASDAQ:KALA) Price Target to $12.00 - Defense World
Kala Bio stock target cut to $12 by H.C. Wainwright, retains buy - Investing.com Nigeria
KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bi - GuruFocus
KALA Stock: HC Wainwright & Co. Adjusts Price Target for Kala Bio | KALA Stock News - GuruFocus
KALA Price Target Reduced by H.C. Wainwright After Q3 Results | - GuruFocus
KALA Price Target Reduced by H.C. Wainwright After Q3 Results | KALA Stock News - GuruFocus
KALA BIO: Q1 Earnings Snapshot - New Haven Register
Persistent Epithelial Defect Market on Track for Major - openPR.com
KALA Focuses on Advancing KPI-012 Development Amid Pivotal Trials | KALA Stock News - GuruFocus
Kala Pharmaceuticals reports Q1 EPS ($1.41) vs ($4.20) last year - TipRanks
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Algorhythm Holdings to Announce its Financial Results for the First Quarter 2025 - The Manila Times
KALA's PCED Drug Could Reach 100,000 PatientsQ3 Trial Results Coming - Stock Titan
Q2 EPS Forecast for Design Therapeutics Reduced by Analyst - Defense World
Research Analysts Set Expectations for Datadog Q2 Earnings - Defense World
B. Riley Issues Negative Estimate for Cadre Earnings - Defense World
HC Wainwright Issues Positive Forecast for Clene Earnings - Defense World
Equities Analysts Issue Forecasts for Cryoport Q2 Earnings - Defense World
B. Riley Forecasts Lower Earnings for Denali Therapeutics - Defense World
Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World
Q2 EPS Estimates for Core Scientific Lifted by HC Wainwright - Defense World
B. Riley Issues Negative Estimate for Fox Factory Earnings - Defense World
KALA BIO (KALA) Projected to Post Quarterly Earnings on Tuesday - Defense World
Q2 Earnings Forecast for Cryoport Issued By Leerink Partnrs - Defense World
KALA BIO (KALA) Projected to Post Earnings on Tuesday - Defense World
Fluence Energy, Inc. (NASDAQ:FLNC) Shares Acquired by Dimensional Fund Advisors LP - Defense World
Dimensional Fund Advisors LP Sells 5,772 Shares of Turning Point Brands, Inc. (NYSE:TPB) - Defense World
Head-To-Head Survey: Equillium (NASDAQ:EQ) and KALA BIO (NASDAQ:KALA) - Defense World
Geode Capital Management LLC Has $426,000 Stake in Sidus Space, Inc. (NASDAQ:SIDU) - Defense World
Geode Capital Management LLC Increases Position in Forte Biosciences, Inc. (NASDAQ:FBRX) - Defense World
Kala Bio Inc (KALA) 財務データ
収益
当期純利益
現金流量
EPS
Kala Bio Inc (KALA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Reumuth Mary | CHIEF FINANCIAL OFFICER |
Jun 24 '25 |
Sale |
4.01 |
3,631 |
14,560 |
62,100 |
| Bazemore Todd | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
4,058 |
16,273 |
83,699 |
| Brazzell Romulus K | SEE REMARKS |
Jun 24 '25 |
Sale |
4.01 |
5,251 |
21,057 |
82,698 |
| Iwicki Mark T | Director |
Jun 24 '25 |
Sale |
4.01 |
13,227 |
53,040 |
258,433 |
1.11%
1.70%
大文字化:
|
ボリューム (24 時間):